Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, including the brain and spinal cord. In MS, the immune system mistakenly attacks the myelin sheath, the protective covering of nerve fibers, causing nerve damage and disrupting communication between the brain and the body. This can lead to a variety of neurological symptoms, including muscle weakness, numbness, vision problems, balance and coordination difficulties, fatigue, and cognitive changes, which may vary in intensity and progression over time.
At SP Medifort Hospital, we provide care at the best hospital for multiple sclerosis, offering patients advanced MS treatment in South India. Our experienced neurologists and multidisciplinary team deliver personalized multiple sclerosis care, including comprehensive diagnosis, disease-modifying therapies, symptom management, rehabilitation, and long-term monitoring.
Recognized for providing the best multiple sclerosis treatment in South India, SP Medifort Hospital focuses on slowing disease progression, reducing relapses, improving neurological function, and enhancing overall quality of life. With cutting-edge diagnostic tools and patient-centered care in South India, we ensure that every patient receives the most effective multiple sclerosis management and support tailored to their individual needs.

Multiple sclerosis can occur in different forms, each with unique patterns of progression and symptom severity.

• Relapsing-Remitting MS (RRMS): Relapsing-Remitting MS (RRMS) is the most common form of multiple sclerosis. It is characterized by clearly defined relapses or flare-ups of symptoms, followed by periods of partial or complete recovery (remission). Patients may experience fatigue, numbness, muscle weakness, or vision problems during relapses, which can be managed with advanced multiple sclerosis therapies.
• Secondary Progressive MS (SPMS): Begins as relapsing-remitting MS but eventually transitions into a phase of steady worsening of symptoms with fewer or no remissions.
• Primary Progressive MS (PPMS): Characterized by a continuous and gradual worsening of neurological function from the onset, without distinct relapses or remissions.
• Progressive Relapsing MS (PRMS): A rare form involving a steady progression of symptoms from the beginning, along with occasional acute relapses.

Risk factors for multiple sclerosis may include:

• Age: Multiple sclerosis is most commonly diagnosed in people between 20 and 50 years old, though it can occur at other ages.
• Female Gender: Women are more likely than men to develop multiple sclerosis, suggesting a possible role of hormones or genetic factors.
• Family History: Having a close relative with MS increases the risk, indicating a genetic component.
• Low Vitamin D or Limited Sunlight Exposure: Insufficient sunlight or low vitamin D levels may contribute to immune system changes that increase Multiple Sclerosis risk.
• Smoking or Certain Viral Infections: Smoking and infections such as the Epstein-Barr virus may trigger or worsen the development of MS in susceptible individuals.
• Race: MS is more common in people of Northern European descent and less common in Asian, African, or Native American populations, though cases in Black and Hispanic individuals may be rising.
• Climate: Temperate regions, such as Canada, the northern United States, Europe, and parts of Australia and New Zealand, show higher MS prevalence.
• Obesity: Childhood or adult obesity can raise the likelihood of developing MS.
• Other Autoimmune Diseases: Conditions like thyroid disease, type 1 diabetes, psoriasis, or inflammatory bowel disease slightly increase MS risk.

Treatment for Multiple Sclerosis (MS) aims to reduce symptoms, manage relapses, slow disease progression, and improve quality of life. At SP Medifort Hospital, patients receive advanced MS treatment in South India, including medical, rehabilitative, and lifestyle interventions tailored to each individual’s needs.

Corticosteroids for MS Relapses: These medications, such as oral prednisone or intravenous methylprednisolone, help reduce nerve inflammation during acute MS relapses. They can relieve symptoms quickly, but may cause side effects like insomnia, high blood pressure, elevated blood sugar, mood changes, and fluid retention.

Plasma exchange for MS (Plasmapheresis): This procedure removes the liquid part of the blood (plasma), replaces it with a protein solution (albumin), and returns it to the body. Plasma exchange may be used for severe or new MS symptoms that do not respond to corticosteroids, helping to reduce inflammation and immune activity.

MS Occupational Therapy: Practical guidance to help manage daily activities and improve quality of life.

Lifestyle Measures: Healthy diet, regular exercise, stress management, and adequate rest to support overall well-being.

Advanced Care: Multidisciplinary programs including rehabilitation, counseling, and specialized neurological support for severe or progressive MS.

Disease-Modifying Therapies (DMTs)For MS: Medications that slow MS progression, reduce the frequency of relapses, and limit new nerve damage.